Atlas Trials

Zelquistinel in the Treatment of Adults With Major Depressive Disorder

Clinical trial NCT03726658 · COMPLETED

Trial details

NCT number
NCT03726658
Sponsor
Syndeio Biosciences, Inc
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Major Depressive Disorder
Start date
2018-11-08
Primary completion
2019-10-23
Enrollment
226

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.